{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:20:58Z","timestamp":1790241658583,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00878-7","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T11:03:21Z","timestamp":1591268601000},"page":"1897-1906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-1792","authenticated-orcid":false,"given":"Mahmoud S.","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"Mosalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Aziz A.","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled S.","family":"Elattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed N.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abla M.","family":"Ebeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00878-7_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-020-00878-7_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study","volume":"167","author":"Blier","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib3","doi-asserted-by":"crossref","unstructured":"Roman M, Irwin MR. Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far. Brain Behav Immun. 2019.","DOI":"10.1016\/j.bbi.2019.09.016"},{"key":"10.1007\/s13311-020-00878-7_bib4","doi-asserted-by":"crossref","first-page":"e1068","DOI":"10.1038\/tp.2017.33","article-title":"Experimental medication treatment approaches for depression","volume":"7","author":"Ionescu","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/neu.2016.69","article-title":"Inflammation and depression: A causal or coincidental link to the pathophysiology?","volume":"30","author":"Leonard","year":"2017","journal-title":"Acta Neuropsychiatr"},{"key":"10.1007\/s13311-020-00878-7_bib6","series-title":"Inflammation-associated depression: evidence, mechanisms and implications","first-page":"117","article-title":"Role of the kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches","author":"Dantzer","year":"2017"},{"key":"10.1007\/s13311-020-00878-7_bib7","series-title":"Inflammation-associated depression: evidence, mechanisms and implications","first-page":"173","article-title":"Inflammation effects on brain glutamate in depression: mechanistic considerations and treatment implications","author":"Haroon","year":"2017"},{"key":"10.1007\/s13311-020-00878-7_bib8","first-page":"4195","article-title":"Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis","volume":"55","author":"K\u00f6hler","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-020-00878-7_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000492619","article-title":"The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"87","author":"El-Haggar","year":"2018","journal-title":"Psychother Psychosom"},{"key":"10.1007\/s13311-020-00878-7_bib10","doi-asserted-by":"crossref","unstructured":"Liu JJ, Wei YB, Strawbridge R, et al. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry 2019.","DOI":"10.1038\/s41380-019-0474-5"},{"key":"10.1007\/s13311-020-00878-7_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1007\/s13311-020-00878-7_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/da.22340","article-title":"Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Zeinoddini","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1007\/s13311-020-00878-7_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2011.07.039","article-title":"Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression","volume":"225","author":"Bah","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-020-00878-7_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharep.2013.08.002","article-title":"Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture","volume":"66","author":"Obuchowicz","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1007\/s13311-020-00878-7_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbr.2011.04.022","article-title":"Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression","volume":"227","author":"Fournier","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-020-00878-7_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12991-017-0161-3","article-title":"Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder","volume":"16","author":"Levada","year":"2017","journal-title":"Ann General Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.psyneuen.2016.02.028","article-title":"Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users","volume":"68","author":"Bot","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1007\/s13311-020-00878-7_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1871530315666150316124019","article-title":"Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect","volume":"15","author":"Saisho","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1007\/s13311-020-00878-7_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1007\/s13311-020-00878-7_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41393-018-0168-x","article-title":"Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy","volume":"56","author":"Afshari","year":"2018","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-020-00878-7_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00210-018-1466-8","article-title":"Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression","volume":"391","author":"Khedr","year":"2018","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1007\/s13311-020-00878-7_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2019\/4651031","article-title":"Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus","volume":"2019","author":"Poggini","year":"2019","journal-title":"Neural Plasticity"},{"issue":"Suppl I","key":"10.1007\/s13311-020-00878-7_bib24","first-page":"9","article-title":"Treatment of patients with comorbid depression and diabetes with metformin and milnacipran","volume":"6","author":"Hofmann","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1007\/s13311-020-00878-7_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"Suppl 20","key":"10.1007\/s13311-020-00878-7_bib26","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib27","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders : (4th ed.) 5th ed. Washington, D.C.: American Psychiatric Association; 2000. xliv, 947."},{"key":"10.1007\/s13311-020-00878-7_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.01.029","article-title":"Meta-analysis of the placebo response in antidepressant trials","volume":"118","author":"Rief","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-020-00878-7_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-244X-12-143","article-title":"Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment","volume":"12","author":"Garcia-Toro","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1461145713000400","article-title":"Rational site-directed pharmacotherapy for major depressive disorder","volume":"17","author":"Blier","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-020-00878-7_bib32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0269881115578160","article-title":"Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial","volume":"29","author":"Gougol","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-020-00878-7_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1176\/appi.ajp.160.4.734","article-title":"When should a trial of fluoxetine for major depression be declared failed?","volume":"160","author":"Quitkin","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.09.033","article-title":"Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study","volume":"189","author":"Balestri","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-020-00878-7_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1007\/s13311-020-00878-7_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/epi-2018-0187","article-title":"Metformin exerts antidepressant effects by regulated DNA hydroxymethylation","volume":"11","author":"Wang","year":"2019","journal-title":"Epigenomics"},{"key":"10.1007\/s13311-020-00878-7_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuro.2019.02.004","article-title":"Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB\/BDNF and Akt\/GSK3 signaling pathways","volume":"72","author":"Keshavarzi","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1007\/s13311-020-00878-7_bib39","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin \u2013 a Future Therapy for Neurodegenerative Diseases","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm Res"},{"key":"10.1007\/s13311-020-00878-7_bib40","doi-asserted-by":"crossref","first-page":"e95884","DOI":"10.1371\/journal.pone.0095884","article-title":"Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00878-7_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2017.09.025","article-title":"Metformin improves obesity-associated inflammation by altering macrophages polarization","volume":"461","author":"Jing","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1007\/s13311-020-00878-7_bib42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status","volume":"119","author":"Cameron Amy","year":"2016","journal-title":"Circ Res"},{"key":"10.1007\/s13311-020-00878-7_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-020-00878-7_bib44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00127-014-0887-z","article-title":"Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors","volume":"49","author":"Baumeister","year":"2014","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1007\/s13311-020-00878-7_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jad.2019.09.013","article-title":"Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK\/CREB-mediated histone acetylation","volume":"260","author":"Fang","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-020-00878-7_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1471-2407-13-235","article-title":"Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells","volume":"13","author":"Karnevi","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1007\/s13311-020-00878-7_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib48","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s13311-017-0527-x","article-title":"Neural Substrates of Depression and Resilience","volume":"14","author":"Han","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-020-00878-7_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40520-014-0194-2","article-title":"Effects of escitalopram on serum BDNF levels in elderly patients with depression: A preliminary report","volume":"26","author":"Martocchia","year":"2014","journal-title":"Aging Clin Exp Res"},{"key":"10.1007\/s13311-020-00878-7_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-020-00878-7_bib51","doi-asserted-by":"crossref","first-page":"e00231","DOI":"10.1002\/prp2.231","article-title":"Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine","volume":"4","author":"Caiaffo","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"10.1007\/s13311-020-00878-7_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0976-500X.77091","article-title":"Jaykaran. Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression","volume":"2","author":"Chavda","year":"2011","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1007\/s13311-020-00878-7_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2015.11.021","article-title":"Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?","volume":"109","author":"Di Rosso","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-020-00878-7_bib54","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jcph.963","article-title":"Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-\u03b1 Level in Patients With Major Depressive Disorder With Severe Depression","volume":"57","author":"Gupta","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"10.1007\/s13311-020-00878-7_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.31887\/DCNS.2005.7.3\/pberney","article-title":"Dose-response relationship of recent antidepressants in the short-term treatment of depression","volume":"7","author":"Berney","year":"2005","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1007\/s13311-020-00878-7_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/appi.ajp.2007.07091453","article-title":"Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents","volume":"165","author":"Emslie","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-020-00878-7_bib57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1262-3636(07)70037-X","article-title":"Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects","volume":"29","author":"Robert","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1007\/s13311-020-00878-7_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/138920006775541561","article-title":"Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450","volume":"7","author":"Mandrioli","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1007\/s13311-020-00878-7_bib59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11739-014-1157-5","article-title":"The role of metformin on vitamin B12 deficiency: a meta-analysis review","volume":"10","author":"Niafar","year":"2015","journal-title":"Intern Emerg Med"},{"key":"10.1007\/s13311-020-00878-7_bib60","doi-asserted-by":"crossref","unstructured":"Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B. Cytokine Research in Depression: Principles, Challenges, and Open Questions. Front Psychiatry. 2019;10(30).","DOI":"10.3389\/fpsyt.2019.00030"},{"key":"10.1007\/s13311-020-00878-7_bib61","doi-asserted-by":"crossref","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-020-00878-7_bib62","doi-asserted-by":"crossref","first-page":"e63648","DOI":"10.1371\/journal.pone.0063648","article-title":"Alterations of serum levels of BDNF-related miRNAs in patients with depression","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00878-7_bib63","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fpsyt.2017.00308","article-title":"Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses","volume":"8","author":"Kishi","year":"2017","journal-title":"Front Psychiatry"}],"updated-by":[{"DOI":"10.1007\/s13311-022-01291-y","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"record-id":"38887"},{"DOI":"10.1007\/s13311-022-01291-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00878-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:53:35Z","timestamp":1761807215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012825"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00878-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00878-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01291-y","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}